The Acquisition Where the Synergy Is Real but the Price Is Not
Meghna Group is bidding for a smaller competitor. The target's standalone free cash flow is BDT 12 crore, growing at 4% in perpetuity, and its WACC is 11%. Meghna expects cost synergies with a present value of BDT 25 crore, but achieving them requires BDT 8 crore of one-off integration costs spread over two years and carries real execution risk. The target has debt of BDT 30 crore that Meghna would assume. The seller is asking BDT 180 crore for the equity. Meghna's own WACC is 9.5% because it is larger and more diversified. The deal team has valued the target by discounting its cash flows at Meghna's 9.5% WACC and adding the full BDT 25 crore of synergies, arriving at a value that comfortably justifies the price.
1. Rebuild the valuation correctly and determine the maximum price Meghna should pay for the equity.
Read the worked answer
Correct discount rate. The target's cash flows should be discounted at the target's WACC of 11%, which reflects the risk of the business being acquired. Using Meghna's 9.5% is wrong: diversification benefits accrue to Meghna's shareholders but do not make the target's cash flows less risky. Using the lower rate inflates value mechanically - at 4% growth, the terminal multiple is 1/(11%−4%) = 14.3x at the correct rate versus 1/(9.5%−4%) = 18.2x, a 27% overstatement.
Standalone enterprise value. 12 × 1.04 / (0.11 − 0.04) = 12.48 / 0.07 ≈ BDT 178 crore. (Using next-year cash flow is the consistent convention; using current cash flow gives 12/0.07 ≈ BDT 171 crore. State which you use.)
Add synergies, net of costs and risk. Synergy PV BDT 25 crore less integration costs of BDT 8 crore ≈ BDT 17 crore gross. Apply a probability or haircut for execution risk - at, say, 70% confidence, BDT 12 crore. Adding the full BDT 25 crore and ignoring the BDT 8 crore is a double error.
Value to Meghna. 178 + 17 = BDT 195 crore enterprise value. Less assumed debt of BDT 30 crore = BDT 165 crore equity value. With the risk haircut, closer to BDT 160 crore.
Maximum price. About BDT 165 crore for the equity, against an ask of BDT 180 crore. The deal destroys value at the asking price by roughly BDT 15 crore, or BDT 20 crore with the risk haircut. Meghna should walk or bid no higher than about BDT 160–165 crore, leaving the seller to justify the gap.
2. The deal team argues that even at BDT 180 crore the acquisition is 'strategically necessary' and that synergies will probably exceed BDT 25 crore. How should the board respond?
Read the worked answer
Separate the strategic case from the price. 'Strategically necessary' is a claim about competitive position, not about value. If the target is genuinely essential, the right response is to bid up to the point where Meghna's shareholders capture some of the synergy - not to surrender all of it. At BDT 180 crore the seller captures the entire synergy PV and more; Meghna's shareholders would be paying BDT 15–20 crore for the privilege of integrating a competitor.
Stress the synergy assumption. The team's 'probably more than BDT 25 crore' is an upward revision made under bidding pressure, which is exactly when synergy estimates are least reliable. Ask for the synergy to be built bottom-up: headcount, duplicate facilities, procurement scale, distribution overlap - and for the cost to achieve it. Integration costs of BDT 8 crore over two years are likely understated; integration programmes routinely overrun. The board should also ask what happens to the BDT 25 crore if the target's customers defect during integration, which is common in competitor mergers.
The discipline test. Set a walk-away price in advance, approved by the board, and give the deal team no authority to exceed it. If the seller will not move below BDT 165 crore, the correct decision is to walk. Walking is a legitimate outcome and often the value-maximising one; the reputational cost of a failed bid is far below the cost of overpaying by 10–15% of equity value.
Alternative structures. If strategic necessity is real, consider an asset purchase of the parts that matter, a minority stake, or a deal with an earn-out tied to realised synergies - which shifts the execution risk back to the seller and tests whether the seller believes its own synergy story.